PetIQ, Inc.
- Jurisdiction
United States - LEI
549300GROACFGKVYOX14 - ISIN
US71639T1060 (PETQ )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
8
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
3
/ 7
Profile
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. Read full profile
Fundamentals
- Net revenue
€967.53M - Gross margin
24.6% - EBIT
€55.54M - EBIT margin
5.7% - Net income
€11.25M - Net margin
1.2%
Statement period: - (published )
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Earnings Calls
Earnings Calls
Latest earnings call: May 8, 2024 (Q1 2024)